Newsfeeds - Spark Newswire

1 minute read

Legal
News

Stealth BioTherapeutics Granted U.S. Patent Titled ‘Methods and compositions for the prevention or treatment of Barth Syndrome’

Today, 11:16 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6643&f=G&l=50&d=PTXT&p=133&S1=20210810&OS=20210810&RS=20210810

MITO

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 11:16 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

1 minute read

Stealth BioTherapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate

By Bill Haddad

Today, 11:16 AM

Stealth BioTherapeutics (NASDAQ:MITO) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent decrease over losses of $(0.02) per share

MITO

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 11:16 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

6 minute read

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

By Shanthi Rexaline

Today, 11:16 AM

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.

ABUS

1 minute read

News

Stealth BioTherapeutics Says Joins Rare Disease Company Coalition

By Benzinga Newsdesk

Today, 11:16 AM

Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today

MITO